Literature DB >> 30389727

Evaluating the Evidence behind Policy Mandates in US Dialysis Care.

Kevin F Erickson1,2,3, Wolfgang C Winkelmayer4.   

Abstract

Keywords:  Economic Analysis; chronic dialysis; end stage kidney disease

Mesh：

Year:  2018        PMID： 30389727      PMCID： PMC6287869          DOI： 10.1681/ASN.2018090905

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  19 in total

1.  Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform.

Authors:  Glenn M Chertow; Jiannong Liu; Keri L Monda; David T Gilbertson; M Alan Brookhart; Anne C Beaubrun; Wolfgang C Winkelmayer; Allan Pollock; Charles A Herzog; Akhtar Ashfaq; Til Sturmer; Kenneth J Rothman; Brian D Bradbury; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2016-02-25       Impact factor: 10.121

2.  Provider visit frequency and vascular access interventions in hemodialysis.

Authors:  Kevin F Erickson; Matthew W Mell; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-13       Impact factor: 8.237

3.  Changes in Medicare reimbursement and patient-nephrologist visits, quality of care, and health-related quality of life.

Authors:  Evelyn K Mentari; Peter B DeOreo; Andrew S O'Connor; Thomas E Love; Edmond S Ricanati; Ashwini R Sehgal
Journal:  Am J Kidney Dis       Date:  2005-10       Impact factor: 8.860

4.  Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform.

Authors:  Kevin F Erickson; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  Am J Kidney Dis       Date:  2016-11-14       Impact factor: 8.860

5.  Evidence-Based Health Policy.

Authors:  Katherine Baicker; Amitabh Chandra
Journal:  N Engl J Med       Date:  2017-12-21       Impact factor: 91.245

6.  Medicare program; end-stage renal disease prospective payment system. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2010-08-12

7.  The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

Authors:  A Besarab; W K Bolton; J K Browne; J C Egrie; A R Nissenson; D M Okamoto; S J Schwab; D A Goodkin
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

8.  Mortality in end-stage renal disease is associated with facility-to-facility differences in adequacy of hemodialysis.

Authors:  W M McClellan; J M Soucie; W D Flanders
Journal:  J Am Soc Nephrol       Date:  1998-10       Impact factor: 10.121

9.  Frequency of patient-physician contact and patient outcomes in hemodialysis care.

Authors:  Laura C Plantinga; Nancy E Fink; John H Sadler; Andrew S Levey; Nathan W Levin; Haya R Rubin; Josef Coresh; Michael J Klag; Neil R Powe
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

10.  Association of provider-patient visit frequency and patient outcomes on hemodialysis.

Authors:  Yelena Slinin; Haifeng Guo; Suying Li; Jiannong Liu; Kristine Ensrud; David T Gilbertson; Allan J Collins; Areef Ishani
Journal:  J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 10.121
View more
  2 in total

1.  The authority of courage and compassion: Healthcare policy leadership in addressing the kidney disease public health epidemic.

Authors:  Franklin W Maddux
Journal:  Semin Dial       Date:  2020-01-09       Impact factor: 3.455

2.  Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD.

Authors:  Keith C Norris; O Kenrik Duru; Radica Z Alicic; Kenn B Daratha; Susanne B Nicholas; Sterling M McPherson; Douglas S Bell; Jenny I Shen; Cami R Jones; Tannaz Moin; Amy D Waterman; Joshua J Neumiller; Roberto B Vargas; Alex A T Bui; Carol M Mangione; Katherine R Tuttle
Journal:  BMC Nephrol       Date:  2019-11-20       Impact factor: 2.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.